Inicio › Cáncer de próstata › South Carolina › Charleston
Ensayos clínicos de Cáncer de próstata en Charleston, SC
15 estudios para Cáncer de próstata buscan participantes en centros de Charleston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
ReclutandoFase 2
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- Medical University of South Carolina, Charleston
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ReclutandoFase 3
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ReclutandoFase 3
- MUSC Hollings Cancer Center, Charleston
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
ReclutandoFase 2
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 1
- Medical University of South Carolina - Hollings Cancer Center, Charleston
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutandoFase 3
- Medical University of South Carolina, Charleston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
ReclutandoFase 1
- Medical University of South Carolina, Charleston
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- Medical University of South Carolina, Charleston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
ReclutandoEstudio observacional
- Ralph H. Johnson VA Medical Center, Charleston
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
ReclutandoFase 2
- Hollings Cancer Center at Medical University of South Carolina, Charleston
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
ReclutandoFase 2
- Medical University of South Carolina Hollings Cancer Center, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Medical University of South Carolina, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site 123, Charleston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutandoFase 3
- Medical University of South Carolina, Charleston
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY103 estudios
- Houston, TX76 estudios
- Los Angeles, CA61 estudios
- Boston, MA59 estudios
- St. Louis, MO46 estudios
- Chicago, IL45 estudios
- San Francisco, CA45 estudios
- Philadelphia, PA44 estudios
- Baltimore, MD43 estudios
- Nashville, TN43 estudios
- Seattle, WA42 estudios
- Washington, DC38 estudios
Otros estudios en Charleston
- Depresión19 estudios
- Accidente cerebrovascular18 estudios
- Fallo cardíaco18 estudios
- Cáncer de pulmón de células no pequeñas16 estudios
- Trastorno de estrés postraumático16 estudios
- Enfermedad cardiovascular15 estudios
- Cáncer (todos los tipos)14 estudios
- Carcinoma de células escamosas de cabeza y cuello14 estudios
- Enfermedad de Parkinson13 estudios
- Enfermedad pulmonar intersticial13 estudios
- Cáncer de seno12 estudios
- Cáncer de pulmón11 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.